Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Prost-Squarcioni

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The British Journal of Dermatology|November 6, 2009
Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatosesS Grootenboer-Mignot, V Descamps, C Picard-Dahan, et al.
Annales De Dermatologie Et De Venereologie|December 25, 2016
[Oral care recommendations for patients with oral autoimmune bullous diseases]V Sobocinski, S-M Dridi, C Bisson, et al.
The British Journal of Dermatology|October 17, 2020
International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoidW Masmoudi, M Vaillant, S Vassileva, et al.
The British Journal of Dermatology|December 21, 2016
Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adultsJ Gottlieb, S Ingen-Housz-Oro, M Alexandre, et al.
The British Journal of Dermatology|January 23, 2016
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigusC Boulard, S Duvert Lehembre, C Picard-Dahan, et al.
The British Journal of Dermatology|November 23, 2017
International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisitaC Prost-Squarcioni, F Caux, E Schmidt, et al.
The British Journal of Dermatology|September 6, 2019
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effectD M Chen, A Odueyungbo, E Csinady, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The British Journal of Dermatology|November 6, 2009
Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatosesS Grootenboer-Mignot, V Descamps, C Picard-Dahan, et al.
Annales De Dermatologie Et De Venereologie|December 25, 2016
[Oral care recommendations for patients with oral autoimmune bullous diseases]V Sobocinski, S-M Dridi, C Bisson, et al.
The British Journal of Dermatology|October 17, 2020
International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoidW Masmoudi, M Vaillant, S Vassileva, et al.
The British Journal of Dermatology|December 21, 2016
Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adultsJ Gottlieb, S Ingen-Housz-Oro, M Alexandre, et al.
The British Journal of Dermatology|January 23, 2016
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigusC Boulard, S Duvert Lehembre, C Picard-Dahan, et al.
The British Journal of Dermatology|November 23, 2017
International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisitaC Prost-Squarcioni, F Caux, E Schmidt, et al.
The British Journal of Dermatology|September 6, 2019
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effectD M Chen, A Odueyungbo, E Csinady, et al.
Pageof 2